Antibodies to Oral Pathobionts and Colon Cancer Risk in the CLUE I Cohort Study. Deberin J, Teles F, Martin LM, Lu J, et al. Int J Cancer 2023 Mar 27. doi: 10.1002/ijc.34527.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Deberin J, Teles F, Martin LM, Lu J, et al. Antibodies to Oral Pathobionts and Colon Cancer Risk in the CLUE I Cohort Study. Int J Cancer 2023 Mar 27. doi: 10.1002/ijc.34527.
PMID: 36971101